Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost ocular surface toxicity study in healthy volunteers
ChiCTR-IPR-15006598Phase 4Recruiting
- Sponsor
- Eye Institute of Xiamen University
- Start
- Jun 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of travoprost (2 arms), sponsored by Eye Institute of Xiamen University. Primary endpoints: corneal sensitivity, aqueous tear production and 3 more. Started Jun 2015; status: recruiting.
02
Drugs
travoprost
Beyond the preview
Go deeper on ChiCTR-IPR-15006598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006598.